CAG
44
-2
LYB
41
2
DFS
70
2
HPE
55
4
JPM
59
3
HD
40
2
UPS
60
4
IP
53
5
LOW
46
4
INTU
50
5
NDAQ
53
-2
HRB
45
3
NEM
59
2
EMC
33
6
CHD
43
11
PLD
41
6
A
58
4
TDC
60
3
RRC
62
2
HCP
64
2
CAG
44
-2
LYB
41
2
DFS
70
2
HPE
55
4
JPM
59
3
HD
40
2
UPS
60
4
IP
53
5
LOW
46
4
INTU
50
5
NDAQ
53
-2
HRB
45
3
NEM
59
2
EMC
33
6
CHD
43
11
PLD
41
6
A
58
4
TDC
60
3
RRC
62
2
HCP
64
2
Financhill
Back

Enterprise Financial Services Vs. Aligos Therapeutics Industry Stock Comparison

Buy
54

EFSC
Enterprise Financial Services

Last Price:
$56.55
Seasonality Move:
-0.4%
Sell
29

ALGS
Aligos Therapeutics

Last Price:
$30.08
Seasonality Move:
-18.25%
Buy
54
Enterprise Financial Services (EFSC) is a Buy

Is Enterprise Financial Services a Buy, Sell or Hold?

  • The current Enterprise Financial Services [EFSC] share price is $56.57. The Score for EFSC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • EFSC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Aligos Therapeutics (ALGS) is a Sell

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $30.05. The Score for ALGS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ALGS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EFSC Stock Price Chart

What is Enterprise Financial Services's stock price today?

  • The Enterprise Financial Services share price today is $56.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EFSC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $30.05
    The current trend is moderately bearish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.

EFSC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.76 Sell
Relative Strength Index (14 RSI): 49.71 Sell
Chaikin Money Flow: 108693 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.22 - 58.92) Sell
Bollinger Bands (100): (50.81 - 58.39) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.14 Buy
Relative Strength Index (14 RSI): 41.89 Sell
Chaikin Money Flow: -263729 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.95 - 41.43) Sell
Bollinger Bands (100): (7.22 - 30.48) Buy

EFSC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.38 Buy
20-day SMA: 56.38 Buy
50-day SMA: 57.85 Sell
200-day SMA: 48.22 Buy
8-day EMA: 55.57 Buy
20-day EMA: 56.36 Buy
50-day EMA: 56.42 Buy
200-day EMA: 50.52 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.28 Sell
20-day SMA: 38.13 Sell
50-day SMA: 27.37 Buy
200-day SMA: 17.35 Buy
8-day EMA: 36.3 Sell
20-day EMA: 36.12 Sell
50-day EMA: 29.44 Buy
200-day EMA: 20.26 Buy

Enterprise Financial Services Earnings Growth & EFSC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.46 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

Enterprise Financial Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):